136 related articles for article (PubMed ID: 38109371)
1. Impact of Cold Ischemia on the Stability of
Ricci A; Dugo M; Pisanu ME; De Cecco L; Raspagliesi F; Valeri B; Veneroni S; Chirico M; Palombelli G; Daidone MG; Podo F; Canese R; Mezzanzanica D; Bagnoli M; Iorio E
J Proteome Res; 2024 Jan; 23(1):483-493. PubMed ID: 38109371
[TBL] [Abstract][Full Text] [Related]
2. Integration of MRI and MRS approaches to monitor molecular imaging and metabolomic effects of trabectedin on a preclinical ovarian cancer model.
Canese R; Palombelli G; Chirico M; Sestili P; Bagnoli M; Canevari S; Mezzanzanica D; Podo F; Iorio E
NMR Biomed; 2019 Oct; 32(10):e4016. PubMed ID: 30375088
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
Canese R; Pisanu ME; Mezzanzanica D; Ricci A; Paris L; Bagnoli M; Valeri B; Spada M; Venditti M; Cesolini A; Rodomonte A; Giannini M; Canevari S; Podo F; Iorio E
NMR Biomed; 2012 Apr; 25(4):632-42. PubMed ID: 22020805
[TBL] [Abstract][Full Text] [Related]
4. In vivo detection of dysregulated choline metabolism in paclitaxel-resistant ovarian cancers with proton magnetic resonance spectroscopy.
Lu J; Li Y; Li YA; Wang L; Zeng AR; Ma XL; Qiang JW
J Transl Med; 2022 Feb; 20(1):92. PubMed ID: 35168606
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI.
Yoon H; Yoon D; Yun M; Choi JS; Park VY; Kim EK; Jeong J; Koo JS; Yoon JH; Moon HJ; Kim S; Kim MJ
PLoS One; 2016; 11(7):e0159949. PubMed ID: 27459480
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of colorectal cancer organoids: A comparison between high-resolution magic angle spinning magnetic resonance spectroscopy and solution nuclear magnetic resonance spectroscopy of polar extracts.
van der Kemp WJM; Grinde MT; Malvik JO; van Laarhoven HWM; Prompers JJ; Klomp DWJ; Burgering B; Bathen TF; Moestue SA
NMR Biomed; 2023 Apr; 36(4):e4882. PubMed ID: 36451530
[TBL] [Abstract][Full Text] [Related]
7. A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours.
Wilson M; Davies NP; Grundy RG; Peet AC
NMR Biomed; 2009 Feb; 22(2):213-9. PubMed ID: 19067434
[TBL] [Abstract][Full Text] [Related]
8. Levels of choline-containing compounds in normal liver and liver metastases of colorectal cancer as recorded by
Ter Voert EEGW; Heijmen L; van Asten JJA; Wright AJ; Nagtegaal ID; Punt CJA; de Wilt JHW; van Laarhoven HWM; Heerschap A
NMR Biomed; 2019 Jan; 32(1):e4035. PubMed ID: 30457686
[TBL] [Abstract][Full Text] [Related]
9. ¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice.
Hekmatyar SK; Wilson M; Jerome N; Salek RM; Griffin JL; Peet A; Kauppinen RA
Br J Cancer; 2010 Oct; 103(8):1297-304. PubMed ID: 20842126
[TBL] [Abstract][Full Text] [Related]
10. Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy.
Pisanu ME; Ricci A; Paris L; Surrentino E; Liliac L; Bagnoli M; Canevari S; Mezzanzanica D; Podo F; Iorio E; Canese R
Br J Cancer; 2014 Feb; 110(3):625-35. PubMed ID: 24335926
[TBL] [Abstract][Full Text] [Related]
11. Impact of intratumoral heterogeneity on the metabolic profiling of breast cancer tissue using high-resolution magic angle spinning magnetic resonance spectroscopy.
Choi JS; Yoon D; Han K; Koo JS; Kim S; Kim MJ
NMR Biomed; 2022 Jun; 35(6):e4682. PubMed ID: 34959254
[TBL] [Abstract][Full Text] [Related]
12. Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts.
Morse DL; Raghunand N; Sadarangani P; Murthi S; Job C; Day S; Howison C; Gillies RJ
Magn Reson Med; 2007 Aug; 58(2):270-80. PubMed ID: 17654590
[TBL] [Abstract][Full Text] [Related]
13. 1H HR-MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas.
Righi V; Roda JM; Paz J; Mucci A; Tugnoli V; Rodriguez-Tarduchy G; Barrios L; Schenetti L; Cerdán S; García-Martín ML
NMR Biomed; 2009 Jul; 22(6):629-37. PubMed ID: 19322812
[TBL] [Abstract][Full Text] [Related]
14. Regional Myo-Inositol, Creatine, and Choline Levels Are Higher at Older Age and Scale Negatively with Visuospatial Working Memory: A Cross-Sectional Proton MR Spectroscopy Study at 7 Tesla on Normal Cognitive Ageing.
Lind A; Boraxbekk CJ; Petersen ET; Paulson OB; Siebner HR; Marsman A
J Neurosci; 2020 Oct; 40(42):8149-8159. PubMed ID: 32994337
[TBL] [Abstract][Full Text] [Related]
15. In vivo MR spectroscopy predicts high tumor grade in endometrial cancer.
Ytre-Hauge S; Esmaeili M; Sjøbakk TE; Grüner R; Woie K; Werner HM; Krakstad C; Bjørge L; Salvesen ØO; Stefansson IM; Trovik J; Bathen TF; Haldorsen IS
Acta Radiol; 2018 Apr; 59(4):497-505. PubMed ID: 28927296
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
17. Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue.
De Silva SS; Payne GS; Thomas V; Carter PG; Ind TE; deSouza NM
NMR Biomed; 2009 Feb; 22(2):191-8. PubMed ID: 18833545
[TBL] [Abstract][Full Text] [Related]
18. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
[TBL] [Abstract][Full Text] [Related]
19. Identification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRS.
Gorad SS; Ellingsen C; Bathen TF; Mathiesen BS; Moestue SA; Rofstad EK
Neoplasia; 2015 Oct; 17(10):767-75. PubMed ID: 26585232
[TBL] [Abstract][Full Text] [Related]
20. 1H MRS identifies specific metabolite profiles associated with MYCN-amplified and non-amplified tumour subtypes of neuroblastoma cell lines.
Peet AC; McConville C; Wilson M; Levine BA; Reed M; Dyer SA; Edwards EC; Strachan MC; McMullan DJ; Wilkes TM; Grundy RG
NMR Biomed; 2007 Nov; 20(7):692-700. PubMed ID: 17506115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
